Asymmetric dimethylarginine levels in patients with coronary artery ectasia.

Journal Title: Kardiologia Polska - Year 2009, Vol 67, Issue 12

Abstract

Endothelial dysfunction might be one of the pathophysiological mechanisms in the development of coronary artery ectasia (CAE) although the exact mechanisms have not yet been demonstrated. Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, is also related to endothelial and structural dysfunction.

Authors and Affiliations

Serkan Cay, Goksel Cagirci, Murat Akcay, Ozlem Karakurt, Erkan Kahraman, Nuray Yazihan, Aytun Canga, Ramazan Akdemir, Sinan Aydogdu

Keywords

Related Articles

Combined renin-angiotensin system gene polymorphisms and outcomes in coronary artery disease - a preliminary report.

Background: Common variants of the renin-angiotensin system (RAS) genes have been linked to a higher risk of coronary artery disease (CAD) and its complications. Aim: To determine the prognostic significance of a combina...

Determinants of physical fitness in males with systolic heart failure.

Heart failure (HF) is a systemic disease which affects mainly older adults. The main symptom of HF is exercise intolerance which in the course of disease can cause limitations in independent functioning. So far no study...

Download PDF file
  • EP ID EP85262
  • DOI -
  • Views 113
  • Downloads 0

How To Cite

Serkan Cay, Goksel Cagirci, Murat Akcay, Ozlem Karakurt, Erkan Kahraman, Nuray Yazihan, Aytun Canga, Ramazan Akdemir, Sinan Aydogdu (2009). Asymmetric dimethylarginine levels in patients with coronary artery ectasia.. Kardiologia Polska, 67(12), 1362-1368. https://europub.co.uk/articles/-A-85262